MNK News and Press, Mallinckrodt plc From 03/13/23

2023-03-13 23:58:45 ET Summary Silence Therapeutics is an underfollowed British siRNA company focusing on cardiovascular and autoimmune diseases. Silence Therapeutics is a de-risked investment opportunity with significant potential upside, supported by its robust pipeline, strateg...

ANI Pharmaceuticals ( NASDAQ: ANIP ) gained ~3% in the morning hours Wednesday, marking the biggest intraday gain since late January, after Guggenheim launched its coverage with a Buy recommendation citing the company’s hormonal autoimmune therapy Cortrophin Gel. Cortrophin...

Mallinckrodt plc (MNK) Q4 2022 Earnings Conference Call February 28, 2023, 8:30 AM ET Company Participants Daniel Speciale - Global Corporate Controller and Chief Investor Relations Officer Sigurdur Olafsson - President and Chief Executive Officer Bryan Reasons - Execu...

Mallinckrodt press release ( NYSE: MNK ): Q4 Non-GAAP EPS of $4.07. Revenue of $489.3M (-18.1% Y/Y). Adjusted EBITDA was $175.5 million Fiscal 2023 Guidance: Adjusted EBITDA is $510 Million to $560 Million; Total sales of $1.70B-$1.82B For further details see: ...

Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance PR Newswire Made Solid Progress on Launch of Terlivaz® with Significant Medical Community Interest Appointed Chief Scientific Officer with Proven Record of Executi...

Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference PR Newswire DUBLIN , Feb. 16, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson , President ...

Mallinckrodt to Report Earnings Results for Fourth Quarter 2022 PR Newswire DUBLIN , Feb. 8, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report fourth quarter 2022 ear...

---------- Company Reports Full Year 2022 Earnings of $3.73 Per Share, or $4.88 Per Share, Excluding Special Items ---------- Company Announces Reorganization and New Segmentation for 2023 ---------- Fourth Quarter Highlights: Sales of $508 Million, 6...

NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today declared a regular quarterly dividend of $0.05 per share on the Company’s common stock. The dividend is payable on March 9, 2023, ...

Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care Congress PR Newswire – Findings from a retrospective analysis suggest that patients with ba...